← Who reports today · Real Estate
DOC · Q2 2026
Archived report (Q2 2026). Latest deep dive →
The quarter in brief
Revenue grew 11.1% y/y to $772M, pre-tax margin 4.2% vs 6.2%, net income $52.7M (+66.9% y/y).
Net income (loss) applicable to common shares
$52.7M
up 66.9% y/y
Total revenues
$772M
up 11.1% y/y
All figures in $M.
| Line item | Amount and change |
|---|---|
| Rental and related revenues | $533 · +0.7% |
| Resident fees and services | $216 · +45.4% |
| Interest income and other | $21.8 · +37.7% |
| Total revenues | $772 · +11.1% |
| Operating | $333 · +20.6% |
| Depreciation and amortization | $283 · +6.6% |
| Interest expense | $92.3 · +22.9% |
| General and administrative | $22.5 · +8.4% |
| Transaction costs and impairments (recoveries), net (calculated) | $7.7 · −43.9% |
| Income before other income, taxes and joint ventures (calculated) | $32.6 · −23.7% · 4.2% margin |
| Income Tax Benefit | $1.4 |
| Total other income (expense), net | $26.8 · vs −$3.1 |
| Equity income (loss) from unconsolidated joint ventures | $2.5 · +43.6% |
| Noncontrolling interests and participating securities (calculated) | $10.6 · +41.7% |
| Net income (loss) applicable to common shares | $52.7 · +66.9% · $0.08/sh · 6.8% margin |
Verdict: revenue grew 11.1% y/y to $772M, pre-tax margin 4.2% vs 6.2%, net income $52.7M (+66.9% y/y).
Diluted EPS $0.08 vs $0.05 a year earlier; diluted FFO as adjusted $0.46 per share, unchanged (non-GAAP); new $500 million share repurchase program authorized.
Source and notation
Source: Healthpeak Properties earnings release and its exhibits, 8-K EX-99 of 08/04/2026 (SEC EDGAR). REIT layout: total revenues as reported; property expenses, depreciation, interest and other items lead to net income (a REIT pays little or no income tax). FFO is a non-GAAP measure: it appears only in the text, as defined by the company, never in the chart. The income statement lines were taken from the release by hand; the program found every figure in the release text and checked the accounting identities and the chart balance; revenue and net income match SEC XBRL.
Open as an image: DOC, Q2 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0
Cite / embed this chart
Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).
Chart: “DOC Q2 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/doc/q2-2026. Licensed under CC BY 4.0.
<figure> <a href="https://whoreportstoday.com/t/doc/q2-2026"><img src="https://whoreportstoday.com/t/doc/q2-2026/sankey.png" alt="DOC Q2 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a> <figcaption>Source: <a href="https://whoreportstoday.com/t/doc/q2-2026">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption> </figure>
https://whoreportstoday.com/t/doc/q2-2026/sankey.png
<a href="https://whoreportstoday.com/t/doc/q2-2026">DOC Q2 2026 earnings chart (Who Reports Today)</a>
This is an archived report: the image at this link won’t change. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.
- Resident fees and services rose to $216.5M from $148.9M as senior housing grew: Janus Living revenue was up 45%.
- Occupancy rose sequentially to 90.7% in Outpatient Medical and to 78.5% in Lab.
- In July 2026 Healthpeak sold a 49% interest in an 86-asset outpatient medical portfolio to Brookfield affiliates at a gross valuation of $2.1 billion, with proceeds of approximately $1.025 billion.
- Pre-tax income was $32.6M, a 4.2% margin vs 6.2% a year earlier.
- Diluted EPS was $0.08 vs $0.05 a year earlier.
What distorts the picture in this report and what to watch beyond the headlines.
DOC — Healthpeak Properties is a healthcare real estate investment trust (REIT) owning outpatient medical buildings, lab space and, through majority-owned Janus Living, senior housing.
Headquarters: Denver, Colorado.
More reports: EQIX · Q3 2026 · ESS · Q3 2026 · EXR · Q3 2026 · FRT · Q2 2026 · HST · Q2 2026 · INVH · Q2 2026 · IRM · Q2 2026 · KIM · Q3 2026 · MAA · Q3 2026 · O · Q3 2026 · all reports